Suchergebnisse - "Liapikou, Adamantia"

PubPharm (51)

1

Emerging antibiotics for community-acquired pneumonia

enthalten in: Expert opinion on emerging drugs | 2019

von Liapikou, A. | Cilloniz, C. | Palomeque, A. | +1

ErratumIn: Expert Opin Emerg Drugs. 2019 Dec;24(4):i. - PMID 31914874

2

Emerging strategies for the noninvasive diagnosis of nosocomial pneumonia

enthalten in: Expert review of anti-infective therapy | 2019

von Liapikou, A. | Cillóniz, C. | Torres, A.

3

Lymphocytopenia as a Predictor of Mortality in Patients with ICU-Acquired Pneumonia

enthalten in: Journal of clinical medicine | 2019

von Ceccato, A. | Panagiotarakou, M. | Ranzani, O. | +9

4

Emerging antibiotics for community-acquired pneumonia

enthalten in: Expert opinion on emerging drugs | 2019

von Liapikou, A. | Cilloniz, C. | Palomeque, A. | +1

5

Drugs that increase the risk of community-acquired pneumonia : a narrative review

enthalten in: Expert opinion on drug safety | 2018

von Liapikou, A. | Cilloniz, C. | Torres, A.

6

Severe community-acquired pneumonia : Characteristics and prognostic factors in ventilated and non-ventilated patients

enthalten in: PloS one | 2018

von Ferrer, M. | Travierso, C. | Cilloniz, C. | +6

7

Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia

enthalten in: PloS one | 2018

von Cillóniz, C. | Liapikou, A. | Martin-Loeches, I. | +7

8

Investigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumonia

enthalten in: Expert opinion on investigational drugs | 2017

von Liapikou, A. | Cillóniz, C. | Torres, A.

9

Investigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumonia

enthalten in: Expert opinion on investigational drugs | 2017

von Liapikou, A. | Cillóniz, C. | Torres, A.

10

Emerging drugs for nosocomial pneumonia

enthalten in: Expert opinion on emerging drugs | 2016

von Liapikou, A. | Torres, A.

1
2
3
4
5
6
Nächster »
[6]